At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 121 enrolled
Drug / intervention
zonisamidedrug
Likely dose
zonisamide 100 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Korean Open-label, Multi-center, Community-based Trial Assessing the Efficacy and Safety of Zonisamide as Adjunctive Therapy in Patients With Uncontrolled Partial Epilepsy
In Brief
A Phase 4 clinical trial evaluating zonisamide for Epilepsy. Completed, enrolled 121 participants across 10 sites.
Detailed Summary
The object of this study is to assess the efficacy and safety of zonisamide as adjunctive therapy in patients with uncontrolled partial epilepsy.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEpilepsy
CountriesSouth Korea
Collaborators--
Timeline
Phase 4CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartFeb 2008
First PostedJun 2010
Primary CompletionAug 2010
Study CompletionMar 2011
TodayJul 2026
First PostedJun 10, 2010
Enrollment StartFeb 29, 2008
Primary CompletionAug 31, 2010
Study CompletionMar 31, 2011
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 16.1 years ago
Interventions
zonisamidedrug
zonisamide 100 mg tablet